Annual Cash & Cash Equivalents:
$3.98B+$2.34B(+143.21%)Summary
- As of today, EW annual cash & cash equivalents is $3.98 billion, with the most recent change of +$2.34 billion (+143.21%) on December 31, 2024.
- During the last 3 years, EW annual cash & cash equivalents has risen by +$2.51 billion (+171.00%).
- EW annual cash & cash equivalents is now at all-time high.
Performance
EW Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$3.84B-$220.70M(-5.43%)Summary
- As of today, EW quarterly cash & cash equivalents is $3.84 billion, with the most recent change of -$220.70 million (-5.43%) on September 30, 2025.
- Over the past year, EW quarterly cash & cash equivalents has dropped by -$606.60 million (-13.63%).
- EW quarterly cash & cash equivalents is now -13.63% below its all-time high of $4.45 billion, reached on September 30, 2024.
Performance
EW Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EW Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +143.2% | -13.6% |
| 3Y3 Years | +171.0% | +120.9% |
| 5Y5 Years | +162.3% | +196.7% |
EW Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +227.3% | -13.6% | +216.1% |
| 5Y | 5-Year | at high | +227.3% | -13.6% | +216.1% |
| All-Time | All-Time | at high | >+9999.0% | -13.6% | >+9999.0% |
EW Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $3.84B(-5.4%) |
| Jun 2025 | - | $4.06B(+4.2%) |
| Mar 2025 | - | $3.90B(-2.0%) |
| Dec 2024 | $3.98B(+143.2%) | $3.98B(-10.6%) |
| Sep 2024 | - | $4.45B(+123.2%) |
| Jun 2024 | - | $1.99B(+17.2%) |
| Mar 2024 | - | $1.70B(+4.0%) |
| Dec 2023 | $1.64B(+34.6%) | $1.64B(-12.2%) |
| Sep 2023 | - | $1.86B(+23.4%) |
| Jun 2023 | - | $1.51B(+20.4%) |
| Mar 2023 | - | $1.25B(+3.2%) |
| Dec 2022 | $1.22B(-17.2%) | $1.22B(-30.1%) |
| Sep 2022 | - | $1.74B(+14.6%) |
| Jun 2022 | - | $1.52B(+1.4%) |
| Mar 2022 | - | $1.50B(+2.0%) |
| Dec 2021 | $1.47B(+4.7%) | $1.47B(-18.6%) |
| Sep 2021 | - | $1.80B(+14.6%) |
| Jun 2021 | - | $1.57B(+18.3%) |
| Mar 2021 | - | $1.33B(-5.1%) |
| Dec 2020 | $1.40B(-7.5%) | $1.40B(+8.3%) |
| Sep 2020 | - | $1.30B(+11.3%) |
| Jun 2020 | - | $1.16B(+12.9%) |
| Mar 2020 | - | $1.03B(-32.0%) |
| Dec 2019 | $1.52B(+58.6%) | $1.52B(+11.8%) |
| Sep 2019 | - | $1.36B(+45.2%) |
| Jun 2019 | - | $934.30M(-3.0%) |
| Mar 2019 | - | $963.00M(+0.7%) |
| Dec 2018 | $956.50M(-28.5%) | $956.50M(-40.1%) |
| Sep 2018 | - | $1.60B(+13.9%) |
| Jun 2018 | - | $1.40B(-6.6%) |
| Mar 2018 | - | $1.50B(+12.1%) |
| Dec 2017 | $1.34B(+5.2%) | $1.34B(-4.7%) |
| Sep 2017 | - | $1.40B(+23.9%) |
| Jun 2017 | - | $1.13B(+23.3%) |
| Mar 2017 | - | $918.20M(-27.8%) |
| Dec 2016 | $1.27B(+3.8%) | $1.27B(+5.9%) |
| Sep 2016 | - | $1.20B(+13.2%) |
| Jun 2016 | - | $1.06B(+11.4%) |
| Mar 2016 | - | $951.80M(-22.3%) |
| Dec 2015 | $1.22B(-14.9%) | $1.22B(-2.1%) |
| Sep 2015 | - | $1.25B(-11.2%) |
| Jun 2015 | - | $1.41B(+2.8%) |
| Mar 2015 | - | $1.37B(-4.7%) |
| Dec 2014 | $1.44B(+53.6%) | $1.44B(-5.0%) |
| Sep 2014 | - | $1.52B(+2.1%) |
| Jun 2014 | - | $1.48B(+78.5%) |
| Mar 2014 | - | $831.60M(-11.2%) |
| Dec 2013 | $936.90M | $936.90M(+23.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $757.60M(+31.8%) |
| Jun 2013 | - | $575.00M(+3.1%) |
| Mar 2013 | - | $557.90M(+7.0%) |
| Dec 2012 | $521.40M(+15.7%) | $521.40M(-16.2%) |
| Sep 2012 | - | $622.50M(+23.0%) |
| Jun 2012 | - | $506.00M(+23.6%) |
| Mar 2012 | - | $409.50M(-9.1%) |
| Dec 2011 | $450.50M(+13.7%) | $450.50M(-0.1%) |
| Sep 2011 | - | $451.10M(-3.7%) |
| Jun 2011 | - | $468.20M(+7.9%) |
| Mar 2011 | - | $433.80M(+9.5%) |
| Dec 2010 | $396.10M(+18.6%) | $396.10M(+9.7%) |
| Sep 2010 | - | $361.00M(+12.7%) |
| Jun 2010 | - | $320.30M(-0.3%) |
| Mar 2010 | - | $321.20M(-3.9%) |
| Dec 2009 | $334.10M(+47.3%) | $334.10M(+15.4%) |
| Sep 2009 | - | $289.50M(+53.7%) |
| Jun 2009 | - | $188.30M(+25.2%) |
| Mar 2009 | - | $150.40M(-33.7%) |
| Dec 2008 | $226.80M(+18.6%) | $226.80M(+5.7%) |
| Sep 2008 | - | $214.50M(+3.1%) |
| Jun 2008 | - | $208.10M(+9.8%) |
| Mar 2008 | - | $189.60M(-0.8%) |
| Dec 2007 | $191.20M(+4.6%) | $191.20M(+8.8%) |
| Sep 2007 | - | $175.70M(+6.5%) |
| Jun 2007 | - | $164.90M(-8.5%) |
| Mar 2007 | - | $180.20M(-1.4%) |
| Dec 2006 | $182.80M(+2.4%) | $182.80M(+20.8%) |
| Sep 2006 | - | $151.30M(-9.5%) |
| Jun 2006 | - | $167.10M(-11.7%) |
| Mar 2006 | - | $189.20M(+5.9%) |
| Dec 2005 | $178.60M(>+9900.0%) | $178.60M(+103.0%) |
| Sep 2005 | - | $88.00M(-8.4%) |
| Jun 2005 | - | $96.10M(+32.4%) |
| Mar 2005 | - | $72.60M(+48.5%) |
| Dec 2004 | - | $48.90M(-20.0%) |
| Dec 2003 | - | $61.10M(+78.7%) |
| Dec 2002 | - | $34.20M(-28.7%) |
| Dec 2001 | - | $48.00M(+104.3%) |
| Sep 2001 | - | $23.50M(-61.9%) |
| Jun 2001 | - | $61.60M(+244.1%) |
| Mar 2001 | - | $17.90M(-36.1%) |
| Dec 2000 | - | $28.00M(+112.1%) |
| Sep 2000 | - | $13.20M(+560.0%) |
| Jun 2000 | - | $2.00M(-66.7%) |
| Mar 2000 | - | $6.00M |
| Dec 1999 | $0.00(0.0%) | - |
| Dec 1998 | $0.00 | - |
FAQ
- What is Edwards Lifesciences Corporation annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Edwards Lifesciences Corporation?
- What is Edwards Lifesciences Corporation annual cash & cash equivalents year-on-year change?
- What is Edwards Lifesciences Corporation quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Edwards Lifesciences Corporation?
- What is Edwards Lifesciences Corporation quarterly cash & cash equivalents year-on-year change?
What is Edwards Lifesciences Corporation annual cash & cash equivalents?
The current annual cash & cash equivalents of EW is $3.98B
What is the all-time high annual cash & cash equivalents for Edwards Lifesciences Corporation?
Edwards Lifesciences Corporation all-time high annual cash & cash equivalents is $3.98B
What is Edwards Lifesciences Corporation annual cash & cash equivalents year-on-year change?
Over the past year, EW annual cash & cash equivalents has changed by +$2.34B (+143.21%)
What is Edwards Lifesciences Corporation quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of EW is $3.84B
What is the all-time high quarterly cash & cash equivalents for Edwards Lifesciences Corporation?
Edwards Lifesciences Corporation all-time high quarterly cash & cash equivalents is $4.45B
What is Edwards Lifesciences Corporation quarterly cash & cash equivalents year-on-year change?
Over the past year, EW quarterly cash & cash equivalents has changed by -$606.60M (-13.63%)